COVID-19
-
Still Bracing for the Surge in Advanced Cancer Cases
The predicted wave of late-stage cancers is taking longer to materialize than we expected.
-
The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer
Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.
-
Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?
Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. Have the rules of the game changed?
-
A now-or-never moment for telehealth?
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
- Let's Go
-
Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
-
A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.
-
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
-
On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care
Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.
-
The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
-
Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.
-
COVID-19 Resources for Providers and Health Plans
A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.
- Loading More...